Send me a link:

*Text messaging rates may apply.

 Dow Down 0.28% Nasdaq Down 0.17%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
13.49 0.03(0.22%) Jul 21, 4:00PM EDT
Prev Close:13.52
Open:13.45
Bid:8.44 x 100
Ask:N/A
1y Target Est:29.50
Beta:0.88
Next Earnings Date:N/A
Day's Range:13.23 - 13.64
52wk Range:4.55 - 19.11
Volume:82,032
Avg Vol (3m):257,002
Market Cap:295.54M
P/E (ttm):N/A
EPS (ttm):-1.33
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALTDown 0.22%295.54M
MNTA565.44M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.94
Quarterly EPS Est (Jun-14) :-0.21
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, is engaged in the research and development of therapies for fibrotic disease and cancer. The company’s lead product candidates include GR-MD-02, a complex polysaccharide polymer for the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback